Neurodegenerative Diseases Drugs Market by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, and Others), by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA), and Others), by Route of Administration (Oral, Injection, Transdermal, and Others), by Distribution Channel (Hospitals, Online Pharmacies, and Retail Pharmacies) – Global Opportunity Analysis and Industry Forecast, 2024–2030
